Dr. John K. Waas
Overview
John K. Waas, DO, is a medical oncologist at UPMC Hillman Cancer Center who practices at Arnold Palmer Medical Oncology at Norwin. Board-certified in medical oncology, Dr. Waas received his medical degree from Philadelphia College of Osteopathic Medicine in Philadelphia. He completed his residency at Lehigh Valley Hospital Center in Allentown, Pa.
Dr. Waas is rated as an Advanced provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Hereditary Resistance to Anti-Vitamin K, Protein S Deficiency, Congenital Antithrombin 3 Deficiency, and Protein C Deficiency.
His clinical research consists of co-authoring 3 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
8775 Norwin Avenue, Suite J, North Huntingdon, PA 15642
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UPMC Hillman Cancer Center
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center. Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute. Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is rated as an Elite provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy.
University Of Pittsburgh Physicians
Marija Balic is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Balic is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Colorectal Cancer, Familial Colorectal Cancer, and Menopause.
West Virginia University Medical Corporation
Sobha Kurian is a Hematologist Oncology specialist and a Hematologist in Morgantown, West Virginia. Dr. Kurian is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Kurian is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Congenital Antithrombin 3 DeficiencyDr. Waas isDistinguished. Learn about Congenital Antithrombin 3 Deficiency.
- Hemangioma Thrombocytopenia SyndromeDr. Waas isDistinguished. Learn about Hemangioma Thrombocytopenia Syndrome.
- Hereditary Resistance to Anti-Vitamin KDr. Waas isDistinguished. Learn about Hereditary Resistance to Anti-Vitamin K.
- Paget Disease of the BreastDr. Waas isDistinguished. Learn about Paget Disease of the Breast.
- Protein C DeficiencyDr. Waas isDistinguished. Learn about Protein C Deficiency.
- Protein S DeficiencyDr. Waas isDistinguished. Learn about Protein S Deficiency.
- Advanced
- AgranulocytosisDr. Waas isAdvanced. Learn about Agranulocytosis.
- Breast CancerDr. Waas isAdvanced. Learn about Breast Cancer.
- Cardiac AmyloidosisDr. Waas isAdvanced. Learn about Cardiac Amyloidosis.
- Cerebral Amyloid AngiopathyDr. Waas isAdvanced. Learn about Cerebral Amyloid Angiopathy.
- Childhood Iron Deficiency Anemia
- Chronic Familial NeutropeniaDr. Waas isAdvanced. Learn about Chronic Familial Neutropenia.
- Experienced
- Adult Soft Tissue SarcomaDr. Waas isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Ampullary CancerDr. Waas isExperienced. Learn about Ampullary Cancer.
- AnemiaDr. Waas isExperienced. Learn about Anemia.
- AngiosarcomaDr. Waas isExperienced. Learn about Angiosarcoma.
- B-Cell LymphomaDr. Waas isExperienced. Learn about B-Cell Lymphoma.